Enfusion, Inc. (ENFN)
NYSE: ENFN · Real-Time Price · USD
10.79
-0.01 (-0.09%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Enfusion Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Enfusion stock have an average target of 12.25, with a low estimate of 11.5 and a high estimate of 13. The average target predicts an increase of 13.53% from the current stock price of 10.79.
Analyst Consensus: Buy
* Price targets were last updated on Dec 23, 2024.
Analyst Ratings
The average analyst rating for Enfusion stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 1 | 2 | 2 | 2 | 2 |
| Sell | 2 | 2 | 2 | 2 | 2 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 6 | 5 | 6 | 6 | 6 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 13, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $10 → $12 | Hold | Maintains | $10 → $12 | +6.58% | Dec 23, 2024 |
| Stifel | Stifel | Strong Buy Maintains $11 → $13 | Strong Buy | Maintains | $11 → $13 | +20.48% | Dec 18, 2024 |
| B of A Securities | B of A Securities | Sell Maintains $8 → $9 | Sell | Maintains | $8 → $9 | -16.59% | Mar 13, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $9 → $8 | Hold → Strong Sell | Downgrades | $9 → $8 | -25.86% | Feb 28, 2024 |
Financial Forecast
Revenue This Year
241.06M
from 201.61M
Increased by 19.57%
Revenue Next Year
280.22M
from 241.06M
Increased by 16.24%
EPS This Year
0.29
from 0.03
Increased by 845.10%
EPS Next Year
0.37
from 0.29
Increased by 31.25%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 252.0M | 294.0M | 336.2M |
| Avg | 241.1M | 280.2M | 318.7M |
| Low | 227.7M | 262.2M | 298.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 25.0% | 22.0% | 20.0% |
| Avg | 19.6% | 16.2% | 13.7% |
| Low | 12.9% | 8.8% | 6.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.36 | 0.47 | 0.42 |
| Avg | 0.29 | 0.37 | 0.40 |
| Low | 0.23 | 0.29 | 0.37 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1,081.4% | 65.4% | 12.0% |
| Avg | 845.1% | 31.2% | 6.1% |
| Low | 645.9% | 2.9% | -0.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.